Embargo Policy

All research presented at the ACG Annual Scientific Meeting is strictly embargoed until 8:00 a.m. on the first day of the Annual Meeting. For 2014, this is Monday, October 20 at 8:00 a.m. EDT.

Poster 1433: Olmesartan-Associated Sprue-Like Enteropathy

Poster Presentation: Tuesday, Oct 21, 10:30 AM – 4:00 PM

Samir A. Shah, MD. FACG
Samir A. Shah, MD. FACG

Author Insight from Samir A. Shah, MD, FACG, Brown University

What’s new here and important for clinicians?
Clinicians, especially gastroenterologists, need to be aware of olmesartan induced diarrhea which gives a sprue like picture endoscopically and histologically, however, antibody testing for sprue is negative. Patients with this entity do not improve with gluten free diet, but do improve completely with stopping of the olmesartan.  The senior author of this abstract (me), saw the patient and had learned of the olmesartan issue from attending an ACG meeting where this was presented a few years ago.

What do patients need to know?
Patients need to know that their medicine list should be reviewed in evaluating diarrhea symptoms and that olmesartan can rarely cause diarrhea.

Read the Abstract

Author Contact
Samir A. Shah, MD, FACG

Related Abstracts
P212 Olmesartan-Associated Spruelike Enteropathy
P808 Olmesartan-Induced Spruelike Enteropathy in the Community Setting
P1427 A Case of Severe Sprue-like Enteropathy Associated With Olmesartan
P1434 Not All Diarrhea and Villous Atrophy Is Celiac Disease: A Case Report on Olmesartan-Induced Enteropathy


Media Interview Requests:

Press room and video recording facilities will be available onsite. To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email jgaulin@gi.org or by phone at 301-263-9000. From Sunday, October 19 – Wednesday, October 22, in ACG Press Room (Room 119A; Phone 215- 418-2358) at the Pennsylvania Convention Center in Philadelphia.